Paul C. Ho

839 total citations · 1 hit paper
15 papers, 702 citations indexed

About

Paul C. Ho is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Paul C. Ho has authored 15 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pharmacology and 3 papers in Pharmacology. Recurrent topics in Paul C. Ho's work include Pharmacological Effects of Natural Compounds (3 papers), Cancer therapeutics and mechanisms (2 papers) and Retinoids in leukemia and cellular processes (2 papers). Paul C. Ho is often cited by papers focused on Pharmacological Effects of Natural Compounds (3 papers), Cancer therapeutics and mechanisms (2 papers) and Retinoids in leukemia and cellular processes (2 papers). Paul C. Ho collaborates with scholars based in Singapore, Sweden and Malaysia. Paul C. Ho's co-authors include Yong Zhang, Ratha Mahendran, Haisheng Qian, Hui Guo, Shanshan Liu, Sui Yung Chan, Jie Su, Ningning Zhang, He Li and Hai‐Shu Lin and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Small.

In The Last Decade

Paul C. Ho

14 papers receiving 690 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mesoporous‐Silica‐Coated Up‐Conversion Fluorescent Nanoparticles for Photodynamic Therapy

2009 528 citations Haisheng Qian, Hui Guo et al. Small profile →

Peers

Countries citing papers authored by Paul C. Ho

Since Specialization

Citations

This map shows the geographic impact of Paul C. Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul C. Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul C. Ho more than expected).

Fields of papers citing papers by Paul C. Ho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul C. Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul C. Ho. The network helps show where Paul C. Ho may publish in the future.

Co-authorship network of co-authors of Paul C. Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Paul C. Ho. A scholar is included among the top collaborators of Paul C. Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul C. Ho. Paul C. Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Determination of Gnetol in Murine Biological Matrices by Liquid Chromatography–Tandem Mass Spectrometry (LC–MS/MS): Application in a Biodistribution Study 2025 ·International Journal of Molecular Sciences ·(unknown), (unknown), Huan Chen, Yuxin Zhang, (unknown), (unknown), Na Li, Shutao Xu, (unknown), Mingming Gao, Xiaoying Zhang, Paul C. Ho, (unknown), Hai‐Shu Lin	0
2	Formulation optimization of scutellarin-loaded HP-β-CD/chitosan nanoparticles using response surface methodology with Box–Behnken design 2017 ·Asian Journal of Pharmaceutical Sciences ·Shanshan Liu, Paul C. Ho	31
3	Validation of a Rapid and Sensitive LC-MS/MS Method for Determination of Exemestane and Its Metabolites, 17β-Hydroxyexemestane and 17β-Hydroxyexemestane-17-O-β-D-Glucuronide: Application to Human Pharmacokinetics Study 2015 ·PLoS ONE ·Lingzhi Wang, (unknown), Andrea Li‐Ann Wong, (unknown), Jieying Amelia Lau, (unknown), Soo Chin Lee, Paul C. Ho, Boon-Cher Goh	17
4	Identification of circulatory and excretory metabolites of meisoindigo in rat plasma, urine and feces by high‐performance liquid chromatography coupled with positive electrospray ionization tandem mass spectrometry 2010 ·Rapid Communications in Mass Spectrometry ·Mengyuan Huang, (unknown), Paul C. Ho	5
5	Mesoporous‐Silica‐Coated Up‐Conversion Fluorescent Nanoparticles for Photodynamic Therapy breakdown → 2009 ·Small ·Haisheng Qian, Hui Guo, Paul C. Ho, Ratha Mahendran, Yong Zhang	528
6	Antiproliferative Activity Against MCF‐7 Breast Cancer Cells by Diamino‐Triazaspirodiene Antifolates 2009 ·Chemical Biology & Drug Design ·Xiang Ma, (unknown), Paul C. Ho, Wai‐Keung Chui	11
7	Identification of Stereoisomeric Metabolites of Meisoindigo in Rat Liver Microsomes by Achiral and Chiral Liquid Chromatography/Tandem Mass Spectrometry 2008 ·Drug Metabolism and Disposition ·Mengyuan Huang, (unknown), Paul C. Ho	4
8	Biopharmaceutics of 13-cis-retinoic acid (isotretinoin) formulated with modified β-cyclodextrins 2007 ·International Journal of Pharmaceutics ·Hai‐Shu Lin, Wendy Wen Yi Leong, Jie Yang, (unknown), Sui Yung Chan, Paul C. Ho	17
9	Determination of thalidomide by high performance liquid chromatography: Plasma pharmacokinetic studies in the rat 2005 ·Journal of Pharmaceutical and Biomedical Analysis ·Xiaoxia Yang, Zeping Hu, Sui Yung Chan, Paul C. Ho, Eli Chan, Wei Duan, Boon Cher Goh, Shu‐Feng Zhou	15
10	Evaluation of Tributyrin Lipid Emulsion with Affinity to Low-Density Lipoprotein: Pharmacokinetics in Adult Male Wistar Rats and Cellular Activity on Caco-2 and HepG2 Cell Lines 2005 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), He Li, Ningning Zhang, Paul C. Ho	18
11	Biopharmaceutics of β-cyclodextrin derivative-based formulations of acitretin in sprague-dawley rats 2004 ·Journal of Pharmaceutical Sciences ·Xin Liu, Hai‐Shu Lin, Sui Yung Chan, Paul C. Ho	7
12	Preparation of Tributyrin Emulsion and Characterization of the Binding of the Emulsion Particles to Low‐Density Lipoprotein in vitro 2004 ·Journal of Pharmaceutical Sciences ·Jie Su, Paul C. Ho	10
13	Determination of tributyrin and its metabolite butyrate in Wistar rat plasma samples by gas chromatography/mass spectrometry 2004 ·Rapid Communications in Mass Spectrometry ·Jie Su, Ningning Zhang, Paul C. Ho	19
14	Polymer-coated microparticles for the sustained release of nitrofurantoin 2002 ·Journal of Pharmacy and Pharmacology ·(unknown), Sui Yung Chan, Paul C. Ho	8
15	Effects of ingredients on stability of captopril in extemporaneously prepared oral liquids 1997 ·American Journal of Health-System Pharmacy ·(unknown), (unknown), Lee Yong Lim, Sui Yung Chan, Eli Chan, Paul C. Ho	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact